Cancer incidence and mortality in France over the 1980-2012 period: solid tumors.
Binder-Foucard, F;
Bossard, N;
Delafosse, P;
Belot, A;
Woronoff, A-S;
Remontet, L;
French network of cancer registries (Francim);
(2014)
Cancer incidence and mortality in France over the 1980-2012 period: solid tumors.
Revue d'epidemiologie et de sante publique, 62 (2).
pp. 95-108.
ISSN 0398-7620
DOI: https://doi.org/10.1016/j.respe.2013.11.073
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
BACKGROUND: Cancer incidence and mortality estimates for 19 cancers (among solid tumors) are presented for France between 1980 and 2012. METHODS: Incidence data were collected from 21 local registries and correspond to invasive cancers diagnosed between 1975 and 2009. Mortality data for the same period were provided by the Institut national de la santé et de la recherche médicale. The national incidence estimates were based on the use of mortality as a correlate of incidence. The observed incidence and mortality data were modeled using an age-period-cohort model. The numbers of incident cases and deaths for 2010-2012 are the result of short-term projections. RESULTS: In 2012, the study estimated that 355,000 new cases of cancer (excluding non-melanoma skin cancer) and 148,000 deaths from cancer occurred in France. The incidence trend was not linear over the study period. After a constant increase from 1980 onwards, the incidence of cancer in men declined between 2005 and 2012. This recent decrease is largely related to the reduction in the incidence of prostate cancer. In women, the rates stabilized, mainly due to a change in breast cancer incidence. Mortality from most cancer types declined over the study period. A combined analysis of incidence and mortality by cancer site distinguished cancers with declining incidence and mortality (e.g., stomach) and cancers with increasing incidence and mortality (e.g., lung cancer in women). Some other cancers had rising incidence but declining mortality (e.g., thyroid). CONCLUSION: This study reveals recent changes in cancer incidence trends, particularly regarding breast and prostate cancers.